Eventide Asset Management’s Sutro Biopharma STRO Stock Holding History

Eventide Asset Management’s Portfolio STRO Stock Details STRO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$17.8M	Buy	+715,307	New	+$12.9M	0.29%	112
2022 Q4	–	Sell	-270,898	Closed	-$15M	–	155
2022 Q3	$15M	Hold	270,898	–	–	0.3%	85
2022 Q2	$14.1M	Hold	270,898	–	–	0.3%	85
2022 Q1	$22.3M	Hold	270,898	–	–	0.35%	81
2021 Q4	$40.3M	Buy	270,898 +33,800	+14%	+$6.06M	0.52%	67
2021 Q3	$44.8M	Hold	237,098	–	–	0.59%	56
2021 Q2	$44.1M	Hold	237,098	–	–	0.59%	55
2021 Q1	$54M	Hold	237,098	–	–	0.8%	45
2020 Q4	$51.5M	Buy	237,098 +38,500	+19%	+$6.37M	0.8%	42
2020 Q3	$20M	Hold	198,598	–	–	0.4%	75
2020 Q2	$15.4M	Buy	198,598 +70,000	+54%	+$6.72M	0.35%	78
2020 Q1	$13.1M	Buy	128,598 +4,108	+3%	+$432K	0.44%	70
2019 Q4	$13.7M	Buy	124,490 +71,990	+137%	+$7.42M	0.39%	70
2019 Q3	$4.77M	Sell	52,500 -71,990	-58%	-$7.27M	0.16%	85
2019 Q2	$13.8M	Hold	124,490	–	–	0.42%	73
2019 Q1	$13.8M	Hold	124,490	–	–	0.47%	67
2018 Q4	$10.9M	Hold	124,490	–	–	0.48%	65
2018 Q3	$18.1M	Buy	+124,490	New	+$18.8M	0.67%	54

Other funds holding STRO

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

Affinity Asset Advisors New York $1.71B AUM 374.45% 1-Year Est. Return

Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return

Kynam Capital Management Princeton, New Jersey $1.58B AUM 138.67% 1-Year Est. Return

OrbiMed New York $4.59B AUM 125.28% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Perceptive Advisors New York $5.06B AUM 314.02% 1-Year Est. Return

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

Point72 Asset Management

Point72 Asset Management Stamford, Connecticut $57.5B AUM 55.25% 1-Year Est. Return

ADAR1 Capital Management Austin, Texas $1.66B AUM 340.85% 1-Year Est. Return